Rofeh Cholim Cancer Society Inc
Rofeh Cholim Cancer Society Inc shows strong revenue growth and high program spending with no reported officer compensation.
EIN: 113355081 · Brooklyn, NY · NTEE: T50Z · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $29.6M |
| Total Expenses | $26.6M |
| Program Spending | 89% |
| CEO/Top Officer Pay | $27.2 |
| Net Assets | $27.2M |
| Transparency Score | 90/100 |
Is Rofeh Cholim Cancer Society Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Rofeh Cholim Cancer Society Inc directs 89% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Rofeh Cholim Cancer Society Inc
Rofeh Cholim Cancer Society Inc (EIN: 113355081) is a nonprofit organization based in Brooklyn, NY, classified under NTEE code T50Z. The organization reported total revenue of $29.6M and total assets of $26.6M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Rofeh Cholim Cancer Society Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Rofeh Cholim Cancer Society Inc is a large nonprofit that has been operating for 29 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 16.0%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $27.2M |
| Total Expenses | $26.6M |
| Surplus / Deficit | +$591K |
| Total Assets | $28.7M |
| Total Liabilities | $1.5M |
| Net Assets | $27.2M |
| Operating Margin | 2.2% |
| Debt-to-Asset Ratio | 5.2% |
| Months of Reserves | 12.9 months |
Financial Health Grade: A
In 2023, Rofeh Cholim Cancer Society Inc reported a surplus of $591K with revenue exceeding expenses, holds 12.9 months of operating reserves (strong position), has a debt-to-asset ratio of 5.2% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), Rofeh Cholim Cancer Society Inc's revenue has grown at a compound annual growth rate (CAGR) of 16.0%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +7.4% | +28.7% | +0.4% |
| 2022 | +11.9% | +44.4% | +16.7% |
| 2021 | +61.8% | +36.2% | +47.1% |
| 2020 | +21.9% | +4.1% | +22.6% |
| 2019 | +6.3% | +19.7% | +13.2% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1997 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Rofeh Cholim Cancer Society Inc with a Mission Score of 90 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 8%
- programs: 89%
- fundraising: 3%
According to IRS 990 filings, Rofeh Cholim Cancer Society Inc allocates its expenses as follows: admin: 8%, programs: 89%, fundraising: 3%. With 89% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $591K, with revenue exceeding expenses.
- Debt-to-asset ratio: 5.2%.
Executive Compensation Analysis
The organization consistently reports 0% officer compensation across all available filings, which is highly unusual for an organization of its size and revenue ($27.2 million in 2023). This suggests that key leadership may be uncompensated volunteers or compensated through mechanisms not categorized as officer compensation on the 990, requiring further scrutiny for full transparency.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Rofeh Cholim Cancer Society Inc's IRS 990 filings:
- Consistent 0% officer compensation reported, which is highly unusual for an organization of this size and revenue, potentially obscuring actual leadership compensation.
Strengths
The following positive indicators were identified for Rofeh Cholim Cancer Society Inc:
- Strong program spending ratio (89% in 2023), indicating efficient use of funds for its mission.
- Significant and consistent revenue growth over the past decade, demonstrating strong fundraising capabilities.
- Healthy financial reserves with assets consistently much higher than liabilities.
- Positive net income in most recent years, contributing to asset growth.
Frequently Asked Questions about Rofeh Cholim Cancer Society Inc
Is Rofeh Cholim Cancer Society Inc a legitimate charity?
Rofeh Cholim Cancer Society Inc (EIN: 113355081) is a registered tax-exempt nonprofit based in New York. Our AI analysis gives it a Mission Score of 90/100. It has 13 years of IRS 990 filings on record. Total revenue: $29.6M. 1 red flag identified. 4 strengths noted. Financial health grade: A.
How does Rofeh Cholim Cancer Society Inc spend its money?
Rofeh Cholim Cancer Society Inc directs 89% of its spending to programs and services. Fundraising costs 3%. This exceeds the 65% industry benchmark.
Are donations to Rofeh Cholim Cancer Society Inc tax-deductible?
Rofeh Cholim Cancer Society Inc is registered as a tax-exempt nonprofit (EIN: 113355081). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Rofeh Cholim Cancer Society Inc CEO make?
Rofeh Cholim Cancer Society Inc's highest-compensated officer earns $27.2 annually. The organization reported $29.6M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Rofeh Cholim Cancer Society Inc's spending goes to programs?
Rofeh Cholim Cancer Society Inc directs 89% to programs, 3% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Rofeh Cholim Cancer Society Inc compare to similar nonprofits?
With a transparency score of 90/100 (Excellent), Rofeh Cholim Cancer Society Inc is above average for NTEE category T50Z nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Rofeh Cholim Cancer Society Inc located?
Rofeh Cholim Cancer Society Inc is headquartered in Brooklyn, New York and files with the IRS under EIN 113355081. It is classified under NTEE code T50Z.
How many years of IRS 990 filings does Rofeh Cholim Cancer Society Inc have?
Rofeh Cholim Cancer Society Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $29.6M in total revenue.
Is Rofeh Cholim Cancer Society Inc a good charity?
Based on its financial filings, Rofeh Cholim Cancer Society Inc appears to be a very good charity. It demonstrates strong financial growth, a high percentage of spending on program services (89% in 2023), and a healthy asset-to-liability ratio. The lack of reported officer compensation is unusual but could indicate a highly volunteer-driven leadership.
How has the organization's revenue grown over time?
The organization has experienced significant revenue growth, increasing from $7,932,791 in 2014 to $27,236,796 in 2023, representing a substantial increase of over 240% in less than a decade.
What is the organization's financial stability?
Rofeh Cholim Cancer Society Inc appears financially stable. In 2023, its assets of $28,730,804 significantly outweighed its liabilities of $1,491,134, indicating a strong financial position and ability to cover its obligations.
What percentage of expenses goes to programs?
In 2023, the organization spent $23,724,500 on program services out of total expenses of $26,645,964, which translates to approximately 89% of its total expenses dedicated to programs.
Filing History
IRS 990 filing history for Rofeh Cholim Cancer Society Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Rofeh Cholim Cancer Society Inc's revenue has grown by 496.7%, moving from $4.6M to $27.2M. Total assets increased by 1292.8% over the same period, from $2.1M to $28.7M. Total functional expenses rose by 514.9%, from $4.3M to $26.6M. In its most recent filing year (2023), Rofeh Cholim Cancer Society Inc reported a surplus of $591K, with revenue exceeding expenses. The organization holds $1.5M in liabilities against $28.7M in assets (debt-to-asset ratio: 5.2%), resulting in net assets of $27.2M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $27.2M | $26.6M | $28.7M | $1.5M | — | — |
| 2022 | $25.4M | $20.7M | $28.6M | $1.5M | — | View 990 |
| 2021 | $22.7M | $14.3M | $24.5M | $1.2M | — | View 990 |
| 2020 | $14.0M | $10.5M | $16.7M | $783K | — | View 990 |
| 2019 | $11.5M | $10.1M | $13.6M | $839K | — | View 990 |
| 2018 | $10.8M | $8.5M | $12.0M | $622K | — | View 990 |
| 2017 | $8.6M | $7.2M | $9.6M | $603K | — | View 990 |
| 2016 | $7.6M | $6.3M | $8.3M | $668K | — | View 990 |
| 2015 | $7.7M | $6.1M | $6.9M | $184K | — | View 990 |
| 2014 | $7.9M | $5.2M | $5.4M | $251K | — | View 990 |
| 2013 | $6.0M | $5.7M | $2.9M | $474K | — | View 990 |
| 2012 | $5.5M | $5.3M | $2.6M | $455K | — | View 990 |
| 2011 | $4.6M | $4.3M | $2.1M | $114K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $27.2M, expenses of $26.6M, and assets of $28.7M (revenue +7.4% year-over-year).
- 2022: Revenue of $25.4M, expenses of $20.7M, and assets of $28.6M (revenue +11.9% year-over-year).
- 2021: Revenue of $22.7M, expenses of $14.3M, and assets of $24.5M (revenue +61.8% year-over-year).
- 2020: Revenue of $14.0M, expenses of $10.5M, and assets of $16.7M (revenue +21.9% year-over-year).
- 2019: Revenue of $11.5M, expenses of $10.1M, and assets of $13.6M (revenue +6.3% year-over-year).
- 2018: Revenue of $10.8M, expenses of $8.5M, and assets of $12.0M (revenue +26.0% year-over-year).
- 2017: Revenue of $8.6M, expenses of $7.2M, and assets of $9.6M (revenue +13.5% year-over-year).
- 2016: Revenue of $7.6M, expenses of $6.3M, and assets of $8.3M (revenue -1.9% year-over-year).
- 2015: Revenue of $7.7M, expenses of $6.1M, and assets of $6.9M (revenue -2.8% year-over-year).
- 2014: Revenue of $7.9M, expenses of $5.2M, and assets of $5.4M (revenue +32.0% year-over-year).
- 2013: Revenue of $6.0M, expenses of $5.7M, and assets of $2.9M (revenue +9.6% year-over-year).
- 2012: Revenue of $5.5M, expenses of $5.3M, and assets of $2.6M (revenue +20.1% year-over-year).
- 2011: Revenue of $4.6M, expenses of $4.3M, and assets of $2.1M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Rofeh Cholim Cancer Society Inc:
Data Sources and Methodology
This transparency report for Rofeh Cholim Cancer Society Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.